CJC-1295 DAC 5mg

Chemical Information:

• Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆
• Molecular Weight: 3647.2 g/mol
• Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Leu-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Ser
• Molecular Structure: Refer to Certificate of Analysis for detailed structural information.

Description:
CJC-1295 (DAC) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), enhanced with Drug Affinity Complex (DAC) technology to extend its biological half-life. It is extensively studied in laboratory research for its potential effects on endogenous growth hormone secretion, cellular repair mechanisms, and metabolic functions. Provided as a lyophilized powder, CJC-1295 (DAC) maintains optimal stability during storage and research applications.

Research Applications:
Laboratory studies involving CJC-1295 (DAC) commonly explore its potential to:

• Promote Growth Hormone Secretion: Investigating prolonged stimulation of growth hormone release for metabolic and cellular function analyses.
• Support Cellular Repair and Recovery: Researching possible influences on tissue regeneration processes and recovery dynamics.
• Explore Fat Metabolism: Examining impacts on lipid metabolism and body composition in experimental models.
• Study Endocrine Function: Evaluating interactions within the hypothalamic-pituitary axis.

Storage and Handling:

• Store lyophilized powder at -20°C.
• Once reconstituted, refrigerate at 2-8°C and use promptly.
• Utilize aseptic techniques during handling to maintain product sterility and quality.

Product Specifications:

• Purity: ≥99% (HPLC Verified)
• Appearance: Lyophilized white powder
• Solubility: Soluble in bacteriostatic water

Important Note:
This product is strictly FOR RESEARCH USE ONLY and is intended exclusively for in vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, cosmetic, or dietary supplement, and has not been evaluated by the FDA. This peptide is not intended to diagnose, treat, cure, or prevent any disease. The bodily introduction into humans or animals is strictly prohibited by law. Any misuse, misbranding, or mislabeling is a violation of federal regulations and may result in legal action under applicable federal, state, or local laws.

References:
Referenced scientific publications include:

• Thompson, M., et al. (2012). “Prolonged Growth Hormone Release with CJC-1295 (DAC).” Endocrine Studies Journal.
• Patel, J., et al. (2018). “Metabolic Effects of GHRH Analogs in Laboratory Models.” Journal of Peptide Science.